Gene expression profiling of human whole blood samples with the Illumina WG-DASL assay

<p>Abstract</p> <p>Background</p> <p>Microarray-based gene expression analysis of peripheral whole blood is a common strategy in the development of clinically relevant biomarker panels for a variety of human diseases. However, the results of such an analysis are often p...

Full description

Bibliographic Details
Main Authors: Klotzle Brandy, April Craig, Shaw Marian, Winn Mary E, Fan Jian-Bing, Murray Sarah S, Schork Nicholas J
Format: Article
Language:English
Published: BMC 2011-08-01
Series:BMC Genomics
Online Access:http://www.biomedcentral.com/1471-2164/12/412
_version_ 1818524292209442816
author Klotzle Brandy
April Craig
Shaw Marian
Winn Mary E
Fan Jian-Bing
Murray Sarah S
Schork Nicholas J
author_facet Klotzle Brandy
April Craig
Shaw Marian
Winn Mary E
Fan Jian-Bing
Murray Sarah S
Schork Nicholas J
author_sort Klotzle Brandy
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Microarray-based gene expression analysis of peripheral whole blood is a common strategy in the development of clinically relevant biomarker panels for a variety of human diseases. However, the results of such an analysis are often plagued by decreased sensitivity and reliability due to the effects of relatively high levels of globin mRNA in whole blood. Globin reduction assays have been shown to overcome such effects, but they require large amounts of total RNA and may induce distinct gene expression profiles. The Illumina whole genome DASL assay can detect gene expression levels using partially degraded RNA samples and has the potential to detect rare transcripts present in highly heterogeneous whole blood samples without the need for globin reduction. We assessed the utility of the whole genome DASL assay in an analysis of peripheral whole blood gene expression profiles.</p> <p>Results</p> <p>We find that gene expression detection is significantly increased with the use of whole genome DASL compared to the standard IVT-based direct hybridization. Additionally, globin-probe negative whole genome DASL did not exhibit significant improvements over globin-probe positive whole genome DASL. Globin reduction further increases the detection sensitivity and reliability of both whole genome DASL and IVT-based direct hybridization with little effect on raw intensity correlations. Raw intensity correlations between total RNA and globin reduced RNA were 0.955 for IVT-based direct hybridization and 0.979 for whole genome DASL.</p> <p>Conclusions</p> <p>Overall, the detection sensitivity of the whole genome DASL assay is higher than the IVT-based direct hybridization assay, with or without globin reduction, and should be considered in conjunction with globin reduction methods for future blood-based gene expression studies.</p>
first_indexed 2024-12-11T05:55:16Z
format Article
id doaj.art-2eee8053314d449f8d748bad9795b05a
institution Directory Open Access Journal
issn 1471-2164
language English
last_indexed 2024-12-11T05:55:16Z
publishDate 2011-08-01
publisher BMC
record_format Article
series BMC Genomics
spelling doaj.art-2eee8053314d449f8d748bad9795b05a2022-12-22T01:18:42ZengBMCBMC Genomics1471-21642011-08-0112141210.1186/1471-2164-12-412Gene expression profiling of human whole blood samples with the Illumina WG-DASL assayKlotzle BrandyApril CraigShaw MarianWinn Mary EFan Jian-BingMurray Sarah SSchork Nicholas J<p>Abstract</p> <p>Background</p> <p>Microarray-based gene expression analysis of peripheral whole blood is a common strategy in the development of clinically relevant biomarker panels for a variety of human diseases. However, the results of such an analysis are often plagued by decreased sensitivity and reliability due to the effects of relatively high levels of globin mRNA in whole blood. Globin reduction assays have been shown to overcome such effects, but they require large amounts of total RNA and may induce distinct gene expression profiles. The Illumina whole genome DASL assay can detect gene expression levels using partially degraded RNA samples and has the potential to detect rare transcripts present in highly heterogeneous whole blood samples without the need for globin reduction. We assessed the utility of the whole genome DASL assay in an analysis of peripheral whole blood gene expression profiles.</p> <p>Results</p> <p>We find that gene expression detection is significantly increased with the use of whole genome DASL compared to the standard IVT-based direct hybridization. Additionally, globin-probe negative whole genome DASL did not exhibit significant improvements over globin-probe positive whole genome DASL. Globin reduction further increases the detection sensitivity and reliability of both whole genome DASL and IVT-based direct hybridization with little effect on raw intensity correlations. Raw intensity correlations between total RNA and globin reduced RNA were 0.955 for IVT-based direct hybridization and 0.979 for whole genome DASL.</p> <p>Conclusions</p> <p>Overall, the detection sensitivity of the whole genome DASL assay is higher than the IVT-based direct hybridization assay, with or without globin reduction, and should be considered in conjunction with globin reduction methods for future blood-based gene expression studies.</p>http://www.biomedcentral.com/1471-2164/12/412
spellingShingle Klotzle Brandy
April Craig
Shaw Marian
Winn Mary E
Fan Jian-Bing
Murray Sarah S
Schork Nicholas J
Gene expression profiling of human whole blood samples with the Illumina WG-DASL assay
BMC Genomics
title Gene expression profiling of human whole blood samples with the Illumina WG-DASL assay
title_full Gene expression profiling of human whole blood samples with the Illumina WG-DASL assay
title_fullStr Gene expression profiling of human whole blood samples with the Illumina WG-DASL assay
title_full_unstemmed Gene expression profiling of human whole blood samples with the Illumina WG-DASL assay
title_short Gene expression profiling of human whole blood samples with the Illumina WG-DASL assay
title_sort gene expression profiling of human whole blood samples with the illumina wg dasl assay
url http://www.biomedcentral.com/1471-2164/12/412
work_keys_str_mv AT klotzlebrandy geneexpressionprofilingofhumanwholebloodsampleswiththeilluminawgdaslassay
AT aprilcraig geneexpressionprofilingofhumanwholebloodsampleswiththeilluminawgdaslassay
AT shawmarian geneexpressionprofilingofhumanwholebloodsampleswiththeilluminawgdaslassay
AT winnmarye geneexpressionprofilingofhumanwholebloodsampleswiththeilluminawgdaslassay
AT fanjianbing geneexpressionprofilingofhumanwholebloodsampleswiththeilluminawgdaslassay
AT murraysarahs geneexpressionprofilingofhumanwholebloodsampleswiththeilluminawgdaslassay
AT schorknicholasj geneexpressionprofilingofhumanwholebloodsampleswiththeilluminawgdaslassay